Breast Cancer 'Immunotherapy' Helps Some With Tough-to-Treat Disease

This news article has expired. Below you will find a short description about the news article and comments that were left by CancerCompass users.

A minority of women with 'triple-negative' tumors responded to Tecentriq, but they responded well

 

0 Comments

You must be logged in to post comments.

We care about your feedback. Let us know how we can improve your CancerCompass experience.